1. A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020) Authors: Grosicki, Sebastian; Lech-Maranda, Ewa; Govind Babu, Kanakasetty; Rybka, Justyna; Litvinskaya, Elena; Loscertales, Javier; Kriachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Blonski, Jerzy; Stefanelli, Tommaso; Vincent, Ghislaine; Banerjee, Hiya; Robak, Tadeusz Journal: Leukemia & lymphoma Issue: Volume 61:Issue 7(2020) Page Start: 1748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial. (31st March 2020) Authors: Offner, Fritz; Robak, Tadeusz; Janssens, Ann; Govind Babu, K.; Kloczko, Janusz; Grosicki, Sebastian; Mayer, Jiri; Panagiotidis, Panagiotis; Schuh, Anna; Pettitt, Andrew; Montillo, Marco; Werner, Olena; Vincent, Ghislaine; Khanna, Sadhvi; Hillmen, Peter Journal: British journal of haematology Issue: Volume 190:Number 5(2020) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma. Issue 1 (January 2015) Authors: Orlowski, Robert Z.; Gercheva, Liana; Williams, Cathy; Sutherland, Heather; Robak, Tadeusz; Masszi, Tamás; Goranova‐Marinova, Vesselina; Dimopoulos, Meletios A.; Cavenagh, James D.; Špička, Ivan; Maiolino, Angelo; Suvorov, Alexander; Bladé, Joan; Samoylova, Olga; Puchalski, Thomas A.; Reddy, Manj... Journal: American journal of hematology Issue: Volume 90:Issue 1(2015:Jan.) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia. (8th August 2014) Authors: Awan, Farrukh T.; Hillmen, Peter; Hellmann, Andrzej; Robak, Tadeusz; Hughes, Steven G.; Trone, Denise; Shannon, Megan; Flinn, Ian W.; Byrd, John C.; the LUCID trial investigators Journal: British journal of haematology Issue: Volume 167:Number 4(2014:Nov.) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial. Issue 31 (1st November 2021) Authors: Byrd, John C.; Hillmen, Peter; Ghia, Paolo; Kater, Arnon P.; Chanan-Khan, Asher; Furman, Richard R.; O'Brien, Susan; Yenerel, Mustafa Nuri; Illés, Arpad; Kay, Neil; Garcia-Marco, Jose A.; Mato, Anthony; Pinilla-Ibarz, Javier; Seymour, John F.; Lepretre, Stephane; Stilgenbauer, Stephan; Robak, Tad... Journal: Journal of clinical oncology Issue: Volume 39:Issue 31(2021) Page Start: 3441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia. Issue 3 (4th March 2022) Authors: Wolska-Washer, Anna; Robak, Tadeusz Journal: Expert review of hematology Issue: Volume 15:Issue 3(2022) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial. Issue 4 (13th February 2017) Authors: Pluta, Agnieszka; Robak, Tadeusz; Wrzesien‐Kus, Agata; Katarzyna Budziszewska, Bozena; Sulek, Kazimierz; Wawrzyniak, Ewa; Czemerska, Magdalena; Zwolinska, Malgorzata; Golos, Aleksandra; Holowiecka‐Goral, Aleksandra; Kyrcz‐Krzemien, Slawomira; Piszcz, Jaroslaw; Kloczko, Janusz; Mordak‐Domagala, Mo... Journal: American journal of hematology Issue: Volume 92:Issue 4(2017:Apr.) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial. Issue 4 (13th February 2017) Authors: Pluta, Agnieszka; Robak, Tadeusz; Wrzesien‐Kus, Agata; Katarzyna Budziszewska, Bozena; Sulek, Kazimierz; Wawrzyniak, Ewa; Czemerska, Magdalena; Zwolinska, Malgorzata; Golos, Aleksandra; Holowiecka‐Goral, Aleksandra; Kyrcz‐Krzemien, Slawomira; Piszcz, Jaroslaw; Kloczko, Janusz; Mordak‐Domagala, Mo... Journal: American journal of hematology Issue: Volume 92:Issue 4(2017:Apr.) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Advances in the pharmacotherapeutic options for primary nodal peripheral T-cell lymphoma. (13th June 2021) Authors: Wolska-Washer, Anna; Smolewski, Piotr; Robak, Tadeusz Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 9(2021) Page Start: 1203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗